Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Autoimmune Diseases × Infliximab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Arthritis, Rheumatoid 7 Melanoma 3 Colitis 3 Carcinoma, Non-Small-Cell Lung 3 Urogenital Neoplasms 2 Lung Neoplasms 2 Inflammatory Bowel Diseases 2 Depressive Disorder, Major 2 Depression 2 Colitis, Ulcerative 2 Vasculitis 1 Takayasu Arteritis 1 Syndrome 1 Stroke 1 Stevens-Johnson Syndrome 1 Spondylitis, Ankylosing 1 Skin Neoplasms 1 Psoriasis 1 Precancerous Conditions 1 Pemphigoid, Benign Mucous Membrane 1 Inflammation 1 Infections 1 Hepatitis C 1 Hematologic Neoplasms 1 Graft vs Host Disease 1 Fatigue 1 Drug-Related Side Effects and Adverse Reactions 1 Depressive Disorder, Treatment-Resistant 1 Cytokine Release Syndrome 1 Crohn Disease 1

Interventions

telitacicept 2 Prednisone 2 Blood Specimen Collection 2 thymoglobulin 1 remdesivir 1 prednylidene 1 fludarabine 1 deltacortene 1 carmustine, poliferprosan 20 drug combination 1 apremilast 1 Vitamin D 1 Valsartan 1 Surveys and Questionnaires 1 Standard of Care 1 Specimen Handling 1 Pyridostigmine Bromide 1 Practice Guidelines as Topic 1 Population Groups 1 Peripheral Blood Stem Cell Transplantation 1 Nivolumab 1 Music Therapy 1 Methods 1 Melphalan 1 Mastectomy, Segmental 1 Mammaplasty 1 Interviews as Topic 1 Infliximab 1 Immunotherapy 1 Immunoglobulins, Intravenous 1 Immune Checkpoint Inhibitors 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01793519 2024-02-28

STARA

Georgetown University

Phase 4 Unknown

Arthritis, Rheumatoid, Autoimmune Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡